Donor T Cells

T cells · Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor T Cells, covering 2017-11-29 to 2017-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]

See pricing